Stryker Research Development from 2010 to 2026
| SYK Stock | USD 366.05 0.20 0.05% |
Research Development | First Reported 1994-03-31 | Previous Quarter 410 M | Current Value 401 M | Quarterly Volatility 112.1 M |
Check Stryker financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Stryker's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.3 B, Interest Expense of 637.4 M or Total Revenue of 26.4 B, as well as many indicators such as Price To Sales Ratio of 3.06, Dividend Yield of 0.0054 or PTB Ratio of 6.39. Stryker financial statements analysis is a perfect complement when working with Stryker Valuation or Volatility modules.
Stryker | Research Development | Build AI portfolio with Stryker Stock |
Historical Research Development data for Stryker serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Stryker represents a compelling investment opportunity.
Latest Stryker's Research Development Growth Pattern
Below is the plot of the Research Development of Stryker over the last few years. It is Stryker's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Stryker's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Stryker Research Development Regression Statistics
| Arithmetic Mean | 900,041,176 | |
| Geometric Mean | 732,726,503 | |
| Coefficient Of Variation | 48.79 | |
| Mean Deviation | 351,620,069 | |
| Median | 862,000,000 | |
| Standard Deviation | 439,162,935 | |
| Sample Variance | 192864.1T | |
| Range | 1.6B | |
| R-Value | 0.98 | |
| Mean Square Error | 7759.7T | |
| R-Squared | 0.96 | |
| Slope | 85,311,275 | |
| Total Sum of Squares | 3085825.3T |
Stryker Research Development History
About Stryker Financial Statements
Stryker investors utilize fundamental indicators, such as Research Development, to predict how Stryker Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Research Development | 1.6 B | 1.7 B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Stryker Correlation against competitors. For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Stryker assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth 0.559 | Dividend Share 3.4 | Earnings Share 8.38 | Revenue Per Share | Quarterly Revenue Growth 0.114 |
The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Stryker's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.